Fluorescent-labeled IgG for Liver Tumor Detection

Summary

This study is to evaluate whether intraoperative fluorescence imaging using fluorescent-labeled IgG probe (FluoAB) can help distinguish the tumor and the liver cirrhosis (or the liver parenchyma). The main purposes of this study include: * To validate the safety and effectiveness of using FluoAB in hepatic surgery. * To raise the surgical precision with guidance by FluoAB fluorescence imaging.

Timeline

Start

2022-05-20

Primary completion

2024-12-31

Completion

2025-06-30

Drugs

Indications